-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DElK9y5hdQfjmTiGKurFfhn1gcMPRQ0Q0lM/iMCsp9JbRgO/ZRpdQOq/G5C4xrH/ URjeJC0qCWgsUYj6dJUwTw== 0001367982-06-000056.txt : 20060808 0001367982-06-000056.hdr.sgml : 20060808 20060808113308 ACCESSION NUMBER: 0001367982-06-000056 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060807 FILED AS OF DATE: 20060808 DATE AS OF CHANGE: 20060808 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KOLTERMAN ORVILLE G CENTRAL INDEX KEY: 0001236394 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 061011736 BUSINESS ADDRESS: BUSINESS PHONE: 8585522200 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-08-07 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001236394 KOLTERMAN ORVILLE G 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 Sr VP Clinical and Regulatory Common Stock 2006-08-07 4 M 0 5000 3.281 A 115941 D Common Stock 2006-08-07 4 S 0 5000 46.928 D 110941 D Common Stock 2006-08-07 4 M 0 7093 12 A 118034 D Incentive Stock Option (right to buy) 12 2006-08-07 4 M 0 7093 0 D 1996-12-01 2006-12-01 Common Stock 7093 0 D Non-Qualified Stock Option (right to buy) 3.281 2006-08-07 4 M 0 5000 0 D 1998-04-09 2008-04-09 Common Stock 5000 18137 D This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. By: /s/Darin M. Lippoldt, Attorney-in-Fact For: Orville G. Kolterman 2006-08-07 -----END PRIVACY-ENHANCED MESSAGE-----